Study details
Enrolling now
Duobrii in Combination With Biologics
Psoriasis Treatment Center of Central New Jersey
NCT IDNCT04119102ClinicalTrials.gov data as of Apr 2026
Phase
Phase 4
Target enrollment
25
Study length
about 11 months
Ages
18+
Locations
1 site in NJ
What this study is about
Researchers are testing Duobrii, a medication, in adults with psoriasis who are already taking biologics. The trial will last for 323 days and involve approximately 25 participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Duobrii
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Dermatology